The worldwide supply and demand of diagnostic tools, pharmaceutical interventions, medical devices, and operations intended to identify, manage, and treat decreased blood flow to the heart muscle, a condition caused by coronary artery disease that affects more than 17.9 million adults in the United States each year, is included in the myocardial ischemia market. The myocardial ischemia market includes imaging equipment, biomarker-based diagnostic kits, medications, interventional devices like catheters and stents, and novel digital health solutions, including wearable monitoring devices and AI-based predictive platforms.